BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Showing BL-8040 Significantly Improves T-cell Infiltration Into the Tumor and Reduces Immunosuppression in the Tumor Microenvironment at ESMO 2018